2023 Leadership Summit

Bio.

Frank Stonebanks has twenty-five years of global executive operational (from sales to 4 time CEO, 2 time founder) and investment experience  in biotech, pharma, med tech, drug delivery and health technology, including executive management, fund formation/capital raising, deal structuring/execution, negotiating, domestic & global marketing, L&A, finance, sales, venture capital investing & senior advisory, in small start-ups, mid-size public companies, large Fortune 50 companies, universities, not for profits, domestic and international and the public sector.

Mr. Stonebanks is currently Co-CEO at Renibus, a cardiorenal focused late-stage biotech company. He is also a Special Advisor at Wavemaker 360 Health, a seed stage health tech Fund in Los Angeles.

Previously Mr. Stonebanks was co-founder and General Partner at Teal Ventures LP, a health technology Fund. Prior to that, Mr. Stonebanks was Senior Advisor to Nova Quest Capital Management, a $3B AUM healthcare private equity fund. Previously Mr. Stonebanks was a Venture Partner at Lumira Ventures, a $400 mm AUM venture fund focused on life sciences, med tech and health technology.  

Mr. Stonebanks was previously CEO, Founder and General Partner of Triphase LP, a biotech-focused fund and operating company, where he raised $75MM of non-dilutive cash, signed a $1.5 B partnership with Celgene (now BMS) and acquired two biopharma products, leading to a successful exit in 2016. Mr. Stonebanks founded Triphase while the Chief Business Officer at the Ontario Institute for Cancer Research (OICR), where he led their investment activities and ran their seed fund. Prior to this Mr. Stonebanks was the Founder and CEO of Zosano (Nasdaq: ZSAN), raising $140 mm and spinning the Macroflux® transdermal technology out of J&J. Prior to this Mr. Stonebanks was CEO of Cynvec, an oncology biotech start-up spun out from NYU focused on the sindbis viral vector, where he raised capital and advanced the program to IND at the FDA.

Mr. Stonebanks was previously a Senior Advisor in IBM’s Corporate Development group, leading healthcare deals and co-managing IBM’s $400 mm fund of funds. Mr. Stonebanks has held senior operating roles at Johnson & Johnson (including at biopharma pioneer Centocor), Sanofi, and Nabi Biopharmaceuticals, including Co-Founder of J&J Internal Ventures (precursor to JLABS)  was an equity investor with JJDC, J&J’s equity investment unit, and led Nabi’s licensing unit.  

Mr. Stonebanks received an M.B.A from Saint Joseph’s University and a B.A. in Kinesiology from the University of Victoria, Canada.